RT Journal Article
SR Electronic
A1 Lederman, Lynne
T1 Teriparatide for Patients with RA and Osteoporosis Requires More Study
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 17
SP 22
OP 22
DO 10.1177/155989771417014
UL http://mdc.sagepub.com/content/14/17/22.abstract
AB Early intensive treatment with methotrexate (MTX) and biologic agents is effective in rheumatoid arthritis (RA), but comorbidities, such as osteoporosis, also require treatment to reduce morbidity and improve quality of life. One treatment is daily teriparatide [European League Against Rheumatism 2014 (abstract OPO276)]. Osteoporosis in patients with RA is multifactorial; excess inflammatory cytokines, corticosteroids used to treat the disease, decreased activity due to joint pain, and postmenopausal osteoporosis are contributory factors.